Parents to be
Director of Hematology, and director of the family and the public Cord Blood Banks at the Chaim Sheba Medical Center, Tel-Hashomer.
Prof. Arnon Nagler is the head of Taburit's Scientific Board.
A pioneer in the use and processing of umbilical cord blood, cord blood banking, stem cells separation and the treatment of patients using stem cells. A world acclaimed leader in his field.
Prof. Nagler has headed Tel Hashomer (Sheba) Cord Blood Bank since 2001.
Professor Nagler is a founding member, and a board member of the European association of umbilical cord blood banks (NetCord), and a cord blood inspector for the American FACT organization for Blood Banks accreditation.
Dr. Nagler is a Professor of Medicine at Tel-Aviv University, Director of Hematology at Chaim Sheba Medical Center, Tel-Hashomer and Director of the Cord Blood Bank.
Under his management, the Sheba Medical Center Cord Blood Bank was accredited by the three prestigious international accreditations: AABB ,NMDP and FACT-NetCord. The Sheba Medical Center Cord Blood Bank is the only European Cord Blood Bank that has been accepted as a full member at the American Association of Cord Blood Banks of the NMDP.
From 1986 until 1989 Dr. Nagler served as a fellow in medicine/hematology at Stanford University School of Medicine (U.S.A.) and specialized in Bone Marrow Transplantation and immunological cellular therapy. He is a member of the American Society of Hematology and Bone Marrow Transplantation.
Dr. Nagler's won a myriad of awards; among his most recent are the Best Abstract Award from the American Society of Bone and Marrow Transplantation (ABSMT) and the Best Abstract from the National Marrow Donor Program Annual Meeting.
Professor Nagler is the Chairman of the Israel's Society of Bone Marrow Transplantation.
Professor Nagler received over forty grants from government, research associations, foundations and pharmaceutical companies for his ongoing research. He holds over forty patents and trademarks, has been the lead investigator on over fifteen clinical trials, is an international sought-after lecturer, and widely published.
Professor Nagler also serves as a medical advisor and a member at Scientific Boards at leading edge biotech and pharmaceutical companies in the fields of Stem Cells, Cord Blood, Bone Marrow Transplantation and Cellular and Immunological therapy.
